Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma Yahoo Finance
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page